Cargando…
Prophylaxis of Venous Thromboembolism with Low Molecular Weight Heparin in Bariatric Surgery: a Prospective, Randomised Pilot Study Evaluating Two Doses of Parnaparin (BAFLUX Study)
BACKGROUND: The optimal dose of low molecular weight heparin (LMWH) to prevent venous thromboembolism (VTE) after bariatric surgery remains controversial. The aim of this multicentre, open-label, pilot study was to evaluate the efficacy and safety of two different doses of the LMWH parnaparin admini...
Autores principales: | Imberti, Davide, Baldini, Edoardo, Pierfranceschi, Matteo Giorgi, Nicolini, Alberto, Cartelli, Concetto, De Paoli, Marco, Boni, Marcello, Filippucci, Esmeralda, Cariani, Stefano, Bottani, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885801/ https://www.ncbi.nlm.nih.gov/pubmed/24163189 http://dx.doi.org/10.1007/s11695-013-1105-x |
Ejemplares similares
-
Update on the clinical use of the low-molecular-weight heparin, parnaparin
por: Camporese, Giuseppe, et al.
Publicado: (2009) -
Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery
por: Du, Wei, et al.
Publicado: (2015) -
Clinical use of parnaparin in major and minor orthopedic sugery: a review
por: Bugamelli, Stefano, et al.
Publicado: (2008) -
Safety of heparin prophylaxis for venous thromboembolism in patients with neurotrauma
por: Puri, G, et al.
Publicado: (2010) -
Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)